$CSBR·8-K

CHAMPIONS ONCOLOGY, INC. · Mar 12, 4:17 PM ET

CHAMPIONS ONCOLOGY, INC. 8-K

Research Summary

AI-generated summary

Updated

Champions Oncology, Inc. Reports Q3 2026 Unaudited Results

What Happened

  • Champions Oncology, Inc. (ticker: CSBR) filed a Form 8-K on March 12, 2026 reporting its unaudited financial results for the third quarter ended January 31, 2026.
  • The company issued a press release announcing those quarterly results; the press release is attached to the 8-K as Exhibit 99.1.

Key Details

  • Filing date: March 12, 2026 (Form 8-K).
  • Reporting item: Item 2.02 — Results of Operations and Financial Condition (unaudited Q3 results).
  • Quarter covered: Third quarter ended January 31, 2026.
  • Exhibit: Press release dated March 12, 2026 included as Exhibit 99.1.

Why It Matters

  • This filing signals Champions Oncology has publicly released its latest quarterly earnings and operational results, which investors use to assess revenue, profitability, and trend direction.
  • Investors should review the attached press release (Exhibit 99.1) and the company’s quarterly financial statements for specific revenue, earnings, and other metrics before making investment decisions.